Collaborative Funder: Andalusia, Spain

---

Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia

Critical limb ischemia (CLI) represents a significant unmet medical need without any approved medical therapies for patients who fail surgical or angioplasty procedures to restore blood flow to the lower leg. CLI affects 2 million people in the U.S. and is associated with an increased risk of leg amputation and death. Amputation rates in patients […]